Notably, in pancreatic cancer, decreased expression of EGLN2 and EGLN3 resulted in the induction of angiogenic factors by HIF1A and TGF-β1 pathway and poor patient OS [28]. This evidence concerns the gene HIF1A and familial pancreatic carcinoma.